UKHC Activators
UKHC activators constitute a diverse group of chemicals that modulate cellular signaling pathways, indirectly influencing the activation state of the UKHC protein. Lithium chloride, for instance, activates the Wnt/β-catenin pathway by inhibiting GSK-3β, leading to the stabilization and nuclear translocation of β-catenin, which in turn activates transcription of genes associated with UKHC. SB-431542, a TGF-β type I receptor inhibitor, indirectly affects UKHC by altering cellular processes associated with TGF-β signaling, creating conditions conducive to UKHC activation. LY294002, a PI3K inhibitor, disrupts the PI3K/AKT pathway, indirectly influencing UKHC through the modulation of cell survival signals and downstream pathways connected to UKHC activation. Resveratrol, known for SIRT1 activation, indirectly activates UKHC by affecting the acetylation state of proteins involved in signaling pathways regulating UKHC. U0126, a MEK1/2 inhibitor, disrupts the MAPK/ERK pathway, indirectly influencing UKHC by altering gene expression through MAPK/ERK signaling modulation.
Cycloheximide, a protein synthesis inhibitor, indirectly activates UKHC by inducing cellular stress responses and perturbing cellular homeostasis, leading to the activation of stress-responsive pathways influencing UKHC activation. A769662, an AMPK activator, indirectly activates UKHC by modulating energy-sensitive pathways, impacting cellular processes regulating UKHC activation in response to changes in energy availability. NSC23766, a Rac1 inhibitor, indirectly activates UKHC by modulating cytoskeletal dynamics, altering the cellular context and signaling pathways connected to UKHC. LY364947, a TGF-β receptor I inhibitor, indirectly activates UKHC by disrupting TGF-β signaling, altering cell behavior and creating conditions favorable for UKHC activation. NDGA, an inhibitor of lipoxygenase, indirectly activates UKHC by modulating lipid signaling, altering lipid metabolism-related pathways connected to UKHC. The collective action of these diverse chemicals showcases the intricate network of signaling pathways through which UKHC activators exert their influence, providing a nuanced understanding of the indirect mechanisms governing UKHC protein activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride is a compound known for its influence on the Wnt/β-catenin signaling pathway. By inhibiting GSK-3β, it activates the Wnt pathway, leading to the inhibition of β-catenin degradation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 is a potent inhibitor of TGF-β type I receptor kinase. While TGF-β signaling is not directly related to the UKHC protein, its downstream effects on various cellular processes can indirectly influence UKHC. Inhibition of TGF-β signaling with SB-431542 may alter the cellular microenvironment, affecting pathways such as cell adhesion and migration. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K (phosphoinositide 3-kinase) inhibitor, impacting the PI3K/AKT signaling pathway. This pathway plays a crucial role in cell survival and growth. By inhibiting PI3K, LY294002 disrupts AKT activation and downstream signaling, potentially influencing pathways connected to UKHC. The indirect activation of UKHC by LY294002 may occur through the modulation of cell survival signals, impacting the cellular context in a way that favors UKHC protein activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a polyphenol known for its impact on SIRT1, a deacetylase implicated in various cellular processes. SIRT1 activation by resveratrol can influence the acetylation status of proteins involved in signaling pathways. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a protein synthesis inhibitor that can indirectly activate UKHC. By globally inhibiting protein synthesis, it induces cellular stress responses, affecting various signaling pathways. This includes pathways related to cell survival and adaptation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an AMPK (AMP-activated protein kinase) activator, modulating cellular energy homeostasis. AMPK activation by A769662 can influence various metabolic pathways, including those associated with the UKHC protein. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $107.00 $156.00 | 4 | |
LY364947 is a selective TGF-β receptor I (ALK5) inhibitor, disrupting TGF-β signaling. While TGF-β is not directly linked to UKHC, its downstream effects on cellular processes can indirectly impact UKHC. Inhibition of TGF-β signaling with LY364947 may alter cell behavior, affecting pathways such as cell proliferation and differentiation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 is a selective inhibitor of p38 MAPK, impacting the p38 MAPK signaling pathway. This pathway is involved in cellular responses to stress and inflammation. The indirect activation of UKHC by SB-203580 is mediated through the modulation of stress-responsive pathways, influencing cellular processes related to inflammation and stress adaptation. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
NDGA is a natural compound known for its inhibitory effects on lipoxygenase enzymes. While not directly related to UKHC, NDGA's impact on lipoxygenase activity can indirectly influence cellular processes associated with UKHC. Lipoxygenases play a role in lipid metabolism, and their inhibition by NDGA may lead to alterations in lipid signaling pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose (2-DG) is a glucose analog that competitively inhibits glucose metabolism. By disrupting glycolysis, 2-DG affects cellular energy homeostasis and signaling pathways related to metabolic adaptation. | ||||||